tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CANF Stock Latest News

Can-Fite BioPharma Announces Special Shareholder Meeting for Capital Restructuring
Company AnnouncementsCan-Fite BioPharma Announces Special Shareholder Meeting for Capital Restructuring
16h ago
6K
CANF
Can-Fite BioPharma Reports H1 2025 Results and Updates
PremiumCompany Announcements
Can-Fite BioPharma Reports H1 2025 Results and Updates
10d ago
CANF
Can-Fite BioPharma Announces Breakthrough in Liver Disease Treatment with Namodenoson
PremiumCompany Announcements
Can-Fite BioPharma Announces Breakthrough in Liver Disease Treatment with Namodenoson
19d ago
6K
CANF
Can-Fite BioPharma announces new findings for Namodenoson
PremiumThe Fly
Can-Fite BioPharma announces new findings for Namodenoson
19d ago
CANF
Can-Fite BioPharma Reports Mid-2025 Financial Results and Drug Development Updates
PremiumCompany Announcements
Can-Fite BioPharma Reports Mid-2025 Financial Results and Drug Development Updates
1M ago
6K
CANF
Can-Fite BioPharma reports 1H EPS 0c vs. 0c last year
PremiumThe FlyCan-Fite BioPharma reports 1H EPS 0c vs. 0c last year
1M ago
CANF
Can-Fite BioPharma Achieves Enrollment Milestone in Pancreatic Cancer Trial
Premium
Company Announcements
Can-Fite BioPharma Achieves Enrollment Milestone in Pancreatic Cancer Trial
2M ago
6K
CANF
Can-Fite achieved over 50% enrollment in Phase 2a trial of Namodenoson
Premium
The Fly
Can-Fite achieved over 50% enrollment in Phase 2a trial of Namodenoson
2M ago
CANF
Can-Fite BioPharma Raises $5 Million in Public Offering
PremiumCompany Announcements
Can-Fite BioPharma Raises $5 Million in Public Offering
2M ago
6K
CANF
Can-Fite BioPharma Announces $15 Million Public Offering
PremiumCompany Announcements
Can-Fite BioPharma Announces $15 Million Public Offering
2M ago
6K
CANF
Can-Fite BioPharma trading resumes
PremiumThe Fly
Can-Fite BioPharma trading resumes
2M ago
CANF
Can-Fite BioPharma trading halted, news pending
PremiumThe Fly
Can-Fite BioPharma trading halted, news pending
2M ago
CANF
Can-Fite BioPharma’s Piclidenoson Shows Promise in Vascular Dementia Treatment
PremiumCompany AnnouncementsCan-Fite BioPharma’s Piclidenoson Shows Promise in Vascular Dementia Treatment
2M ago
6K
CANF
Can-Fite BioPharma announces group from UCLA demonstrate Piclidenoson efficacy
Premium
The Fly
Can-Fite BioPharma announces group from UCLA demonstrate Piclidenoson efficacy
2M ago
CANF
Can-Fite BioPharma files to sell 4.9M American depositary shares
Premium
The Fly
Can-Fite BioPharma files to sell 4.9M American depositary shares
2M ago
CANF
Can-Fite BioPharma’s Shareholders Approve Key Proposals at Annual Meeting
PremiumCompany Announcements
Can-Fite BioPharma’s Shareholders Approve Key Proposals at Annual Meeting
3M ago
6K
CANF
Can-Fite BioPharma Reschedules Annual Meeting Due to Lack of Quorum
PremiumCompany Announcements
Can-Fite BioPharma Reschedules Annual Meeting Due to Lack of Quorum
3M ago
6K
CANF
Can-Fite BioPharma to Present Pancreatic Cancer Study Progress at BIO 2025
PremiumCompany Announcements
Can-Fite BioPharma to Present Pancreatic Cancer Study Progress at BIO 2025
4M ago
6K
CANF
Can-Fite BioPharma to present Phase IIa pancreatic cancer study progress
PremiumThe Fly
Can-Fite BioPharma to present Phase IIa pancreatic cancer study progress
4M ago
CANF
Can-Fite BioPharma Announces June 2025 Shareholder Meeting
PremiumCompany AnnouncementsCan-Fite BioPharma Announces June 2025 Shareholder Meeting
5M ago
6K
CANF
Can-Fite BioPharma Secures $175 Million for Phase III Trials
Premium
Company Announcements
Can-Fite BioPharma Secures $175 Million for Phase III Trials
5M ago
6K
CANF
Can-Fite raises $175M to date for namodenoson, piclidenoson development
Premium
The Fly
Can-Fite raises $175M to date for namodenoson, piclidenoson development
5M ago
CANF

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >